NDC directory

Dasatinib

dasatinib · Quallent Pharmaceuticals Health LLC · TABLET, FILM COATED

82009-197ANDACytochrome P450 3A4 Inhibitors [MoA]
Product NDC
82009-197
Generic name
dasatinib
Labeler name
Quallent Pharmaceuticals Health LLC
Brand name
Dasatinib
Finished
true
Listing expiration date
20271231
Marketing category
ANDA
Dosage form
TABLET, FILM COATED
SPL ID
669a5206-88e3-1014-a561-aa33f2b7b3a7
Product type
HUMAN PRESCRIPTION DRUG
Marketing start date
20261102
Product ID
82009-197_669a5206-88e3-1014-a561-aa33f2b7b3a7
Application number
ANDA217217
Brand name base
Dasatinib
Active ingredients
  1. Name
    DASATINIB
    Strength
    140 mg/1
Packaging
  1. Package NDC
    82009-197-30
    Description
    30 TABLET, FILM COATED in 1 BOTTLE (82009-197-30)
    Marketing start date
    20261102
    Sample
    false
Route
ORAL
Pharm class
Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.